187
Participants
Start Date
February 2, 2021
Primary Completion Date
June 17, 2022
Study Completion Date
December 31, 2026
Elranatamab (PF-06863135)
BCMA-CD3 bispecific antibody
ZNA-Middelheim, Antwerp
ZNA Stuivenberg, Antwerp
Universitair Ziekenhuis Antwerpen, Edegem
Epworth Healthcare, East Melbourne
The Alfred, Melbourne
St Vincent's Hospital (Melbourne), Fitzroy
Epworth Healthcare, Richmond
CHU UCL Namur site Godinne, Yvoir
Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care, New York
Weill Cornell Medical College - New York Presbyterian Hospital, New York
Weill Cornell Medical College - New York-Presbyterian Hospital, New York
Memorial Sloan Kettering Cancer Center, New York
Weill Cornell Medical College - New York Presbyterian Hospital, New York
Memorial Sloan Kettering Cancer Center - Investigational Drug Service Pharmacy, Long Island City
Roswell Park Cancer Institute, Buffalo
Complejo Hospitalario Universitario de Santiago, Santiago de Compostela
Fox Chase Cancer Center, Philadelphia
Universitätsklinikum Hamburg - Eppendorf, Hamburg
Universitätsklinik Schleswig-Holstein, Kiel
Clinica Universitaria de Navarra, Madrid
Hospital Universitario 12 de Octubre, Madrid
St Francis Physician Services Inc, Greenville
St. Francis Hospital, Greenville
Saint Francis Hospital Cancer Center, Greenville
St Francis Eastside, Greenville
Winship Cancer Institute @ Emory University Hospital Midtown, Atlanta
Emory University Hospital, Atlanta
Emory University, Atlanta
Winship Cancer Institute, Emory University, Atlanta
Blood and Marrow Transplant Group of Georgia, Atlanta
Emory Saint Joseph's Hospital, Atlanta
Northside Hospital, Atlanta
Clinica Universitaria de Navarra, Pamplona
Baptist Hospital of Miami, Miami
Norton Cancer Institute, St. Matthews Campus, Louisville
Norton Women's and Children's Hospital, Louisville
CHU de Nantes - Hôtel Dieu, Nantes
Hospital Universitario Doctor Peset, Valencia
Cancer Center Associates LLC, Indianapolis
Franciscan Health, Indianapolis
Indiana Blood and Marrow Transplantation, Indianapolis
State University of Iowa, Iowa City
University of Iowa - Holden Comprehensive Cancer Center, Iowa City
CHU de Lille - Hopital Claude Huriez, Lille
Loyola University Chicago performing research at Loyola University Medical Center, Maywood
Loyola University Medical Center, Maywood
Northwestern Medical Group, Chicago
Northwestern Memorial Hospital, Chicago
Universitätsklinikum Heidelberg, Heidelberg
Centre Hospitalier Lyon Sud - Service d'Hematologie Clinique, Pierre-Bénite
Ochsner Clinic Foundation, New Orleans
Hopital Saint-Louis, Paris
Hôpital Saint-Antoine, Paris
Baylor Scott & White Research Institute, Dallas
Baylor University Medical Center, Baylor Scott & White, Dallas
Baylor University Medical Center, Dallas
CHU de Poitiers, Pôle Régional de Cancérologie, Poitiers
Ronald Reagan UCLA Medical Center Drug information Center, Los Angeles
The Regents of the University of California, Los Angeles
UCLA Hematology/Oncology Clinic, Los Angeles
UCLA Ronald Reagan Medical Center, Los Angeles
Beverly Hills Cancer Center, Beverly Hills
The Regents of the University of California, Irvine
UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange
Massachusetts General Hospital, Boston
Hackensack University Medical Center, Edison
Hackensack University Medical Center, Hackensack
John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
Regional Cancer Care Associates, LLC, Hackensack
Arthur J.E. Child Comprehensive Cancer Centre, Calgary
Cross Cancer Institute, Edmonton
Alberta Health Services and The Governors of The University of Alberta, Edmonton
CIUSSS-EMTL, Installation Hopital Maisonneuve-Rosemont, Montreal
Jewish General Hospital, Montreal
McGill University Health Centre - Glen Site, Montreal
Klinikum Chemnitz gGmbH, Chemnitz
Nagoya City University Hospital, Nagoya
Gunma University Hospital, Maebashi
Kobe City Medical Center General Hospital, Kobe
Iwate Medical University Hospital, Yahaba-cho
Tohoku University Hospital, Sendai
Japanese Red Cross Medical Center, Shibuya-ku
Yamagata University Hospital, Yamagata
Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wroclawiu, Wroclaw
Szpital Uniwersytecki nr 2 im. dr Jana Biziela w Bydgoszczy, Bydgoszcz
Szpital Kliniczny im. Heliodora Święcickiego UM w Poznaniu, Poznan
Institut Catala d' Oncologia. Hospital Universitari Germans Trias i Pujol, Badalona
Hospital Clinic de Barcelona, Barcelona
The Christie NHS Foundation Trust, Manchester
Lead Sponsor
Pfizer
INDUSTRY